A Phase Ib Safety and Pharmacokinetics (PK)/ Pharmacodynamics (PD) Study to Determine the Dosage of Abraxane in Combination with Phenelzine Sulfate in Metastatic or Inoperable Locally Advanced Breast Cancer
Phase of Trial: Phase I
Latest Information Update: 06 Mar 2018
At a glance
- Drugs Paclitaxel (Primary) ; Phenelzine (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Proof of concept
- Acronyms Epi-PRIMED
- Sponsors EpiAxis Therapeutics
- 15 Jan 2018 Planned End Date changed from 25 Sep 2018 to 1 Mar 2019.
- 15 Jan 2018 Status changed from not yet recruiting to recruiting.
- 01 Oct 2017 According to an EpiAxis Therapeutics medis release, first patient has been recruited.